Stephen Davis Lab : Selected Publications

Selected Publications

1. Kaiser M, Gil J, Treu R, Valdes J and Davis SC. An In Vitro Analysis of the Effects of Various Topical Antimicrobial Agents on Methicillin-resistant and methicillin-sensitive Strains of Staphylococcus aureus Ostomy Wound Management 2014;60(4):18–28

2. Li J, Ollague Sierra J, Zhu L, Tang L, Rahill K, El-Sabawi B, Liu-Mares W, Mertz PM, Davis SC. Effects of a topical aqueous oxygen emulsion on collagen deposition and angiogenesis in a porcine deep partial-thickness wound model. Experiment Dermatol, 22: 674-676, 2013. DOI: 10.1111/exd.12225

3. Bionda N, Pastar I, Davis SC, Cudic P. In Vitro and In Vivo Activities of Novel Cyclic Lipopeptides Against Staphylococcal Biofilms. Protein Pept Lett 2013, Oct 25 PMID:24164269
4. Davis SC, Li J, Gil J, Valdes J, Solis M, Treu R, Kirsner RS. A Closer Examination of Atraumatic Dressings for Optimal Healing. Int Wound J 2013 Sept 13 PMID: 24028503
5. Phillps PL, Yang Q, Davis SC, Sampson EM, Azeke JI, Hamad A, Schultz GS. Antimicrobial Dressing Efficacy Against mature Pseudomonas aerugionsa Biofilm on Porcine Skin Explants. Int Wound J. 2013 Sept 13. PMID: 24028432
6. Pastar I, Nusbaum AG, Gil J, Patel SB, Chen J, Valdes J, Stojadinovic O, Plano LR, Tomic-Canic M, Davis SC. Interactions of Methicillin-Resistant Staphylococcus aureus USA300 and Pseduomonas aeruginosa in Polymicrobial Wound Infection. PLOS One, February 2013
7. Shumaker PR, Kwan JM, Badiavas EV, Waibel J, Davis SC, Uebelhoer NS. Rapid Healing of Scar Associate Chronic Wounds after Ablative Fractional Resurfacing. Arch Dermatol 2012;148(11):1289-1293
8. Harding AC, Gil J, Valdes J, Solis M, Davis SC. Efficacy of a Bio-electric Dressing in Healing Partial Thickness Wounds using a Porcine Model. Ostomy Wound Manage. 2012; 58(9):50-55.
9. Escandon J, Vivas AC, Perez R, Kirsner R, Davis S. A Prospective Pilot Study of Ultrasound Therapy Effectiveness in Refractory Venous Leg Ulcers. Int Wound J 2012; 9:570-578.
10. Pechter PM, Gil J, Valdes J, Tomic-Canic M, Pastar I, Stojadinovic O, Kirsner RS, Davis SC. Keratin dressings speed epithelialization of deep partial thickness wounds. Wound Repair Regen. 2012 Mar-Apr;20(2):236-42.
11. Nusbaum AG, Gil J, Rippy MK, Warne B, Valdes J, Claro A, Davis SC. Effective Method to Remove Wound Bacteria: Comparison of Various Debridement Modalities in an In Vivo Porcine Model J Surg Res 2012, 176(2):701-7
12. Haag WG, Abril-Horpel O, Becquerelle SD, Mertz PM and Davis SC. Statistical approach for avoiding pseudoreplication and increasing power in wound healing studies. 2011 Wound Repair Reg 19(3); 442-8

13. Vukelic S, Stojadinovic O, Pastar I, Rabach M, Krzyzanowska A, Lebrun E, Davis SC, Resnick S, Brem H, Tomic-Canic M. Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. 2011 J Biol Chem 286,12 10265-10275

14. Stojadinovic O, Lebrun E, Pastar I, Kirsner R, Davis SC, Tomic-Canic M. Statins as potential therapeutic agents for healing disorders. 2010 Expert Review of Dermatology 5(6), 689-698

15. Tang L, WuJJ, MaQ, CuiT, Andreopoulos FM, Gil J. Valdes J, Davis SC, Li J. Human lactoferrin stimulates skin keratinocyte function and wound reepithelialization Br J Dermatol 2010 Jul;163(1):38-47

16. Huo R, Ma Q, Wu JJ, Chin-Nuke K, Jing Y, Chen J, Miyar ME, Davis SC, Li J Noninvasive Electromagnetic Fields on Keratinocyte Growth and Migration. J Surg Res 2009 Mar 21, 1-9

17. Charles CA, Ricotti, CA, Davis SC, Mertz PM and Kirsner RS. Use of Tissue-Engineered Skin to Study in vitro biofilm development Dermatol Surg 2009 Sep;35(9):1334-41

18. Davis SC and Perez R. Cosmeceuticals and natural products: wound healing. Invited: Epstein H. – Clin Dermatol 2009 Sep-Oct;27(5):502-6.

19. Gomer RH, Pilling D, Kauvar L, Ellsworth S, Ronkainen SD, Roife D, and Davis SC. A Serum Amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigs Wound Rep Regen 2009 17:397–404

20. Davis SC and Mertz PM: Treatment of Wounds with an Oak Bark Formulation: Antimicrobial and Wound Healing Assessments. Ostomy Wound Management 2008 Oct;54(10):16-25

21. Davis SC, Pisanni F, Montero RB: Effects of commonly used topical antimicrobial agents on Acinetobacter baumannii: An In-Vitro Study Mil Med. 2008 Jan;173(1):74-8

22. Perez R and Davis SC. Relevance of Animal Models for Wound Healing. Wounds 2008, 20(1); 1-7.

23. Martineau L and Davis SC. Controlling Methicillin Resistant Staphylococcus aureus and Pseudomonas aeruginosa wound infections with a novel biomaterial. J Invest Surgery 2007, 20;217-227.

24. Davis SC, Ricotti C, Cazzaniga AL, Welch E, and Mertz PM. Microscopic and Physiological Evidence for Biofilm-Associated Wound Colonization In-vivo Wound Repair Regen 2008, 16(1):23-9.

25. Mertz PM, Cardenas TCP, Snyder RV, Kinney ML, Davis SC, Plano LR.W. Staphylococcus aureus virulence factors associated with infected skin lesions: influence on the local immune response. Arch Dermatol 2007; 143(10): 1259-1263

26. Davis SC, Ricotti C, Zalesky P, Hsu L, Creech J, and Mertz PM Topical Oxygen Emulsion: A Novel Wound Therapy Arch Dermatol 2007;143(10):1252-1256

27. Bouzari N, Davis SC, Nouri K. Laser treatment of keloids and hypertrophic scars. Int’l J Dermatol, 2007 Jan;46(1):80-8.

28. Davis SC, Martinez L, Kirsner R The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep 2006 Dec;6(6):439-45.

29. Davis SC, Cazzaniga AL, Eaglstein WH, and Mertz PM. Over-The-Counter Antimicrobial Bandages and Proliferation of a Common Wound Pathogen. Arch Dermatol Res. 2005 Nov;297(5):190-5.

30. Davis SC and Bouzari N. Development of Antimicrobials for Wound Care:” In-vitro and In-vivo Assessments. Wounds 2004; 16(11):344-347

31. Berman B, Ricotti C, Cazzaniga A, and Davis SC. Determination of the area of skin capable of being covered by the application of 250 mg of imiquimod 5% cream Dermatol Surg 2004 May;30(5):784-6

32. Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM. A Wound-Isolated Pseudomonas aeruginosa Grows a Biofilm In Vitro Within 10 Hours and is Visualized by Light Microscopy. Dermatol Surg 2003 Jun;29(6):631-5.

33. Davis SC (roundtable participant), Topical Antibiotic Therapy: Changing Antibiotic Susceptibility Patterns and Clinical Implications. (In Proceedings from a Clinical Roundtable) A Supplement to Cutis, Vol. 71, No. 3S, March 2003.

34. Mertz, PM., Davis, SC, Cazzaniga, A., Drosou, A., Eaglstein, W. Barrier and Antibacterial Properties of 2-Octyl Cyanoacrylate Derived Wound Treatment Films J Cutaneous Medicine and Surgery 2003;7,1, 1-12.

35. Davis SC, Mertz PM, Cazzaniga AL, Serralta V, Orr R, and Eaglstein, WH. The Use of New Antimicrobial Gauze Dressings: Effects on the Rate of Epithelialization of Partial-Thickness Wounds. Wounds, 2002; 14, (7);252-256.

36. Cazzaniga, A., Seralta, V., Davis SC, Orr R, Eaglstein, W., Mertz, P. The Effect of an Antimicrobial Gauze Dressing Impregnated with 0.2-Percent Polyhexamethylene Biguanide as a Barrier to Prevent Pseudomonas aeruginosa Wound Invasion. Wounds 2002;14, 5 169-176.

37. Davis, SC, Eaglstein WH, Cazzaniga AL, and Mertz PM. An Octyl-2- Cyanoacrylate Formulation Speeds Healing of Partial Thickness Wounds Dermatol Surg 2001; 27:783-788.

38. Sullivan TP, Eaglstein WH, Davis SC, and Mertz PM. The pig as a model for human wound healing. Wound Repair and Regeneration 2001, 9 (2) 66-76

39. Serralta VW, Harrison-Balestra C, Cazzaniga AL, Davis SC, and Mertz PM. Lifestyles of bacteria in wounds: presence of biofilms? Wounds 2001; 13, 1, 29-34.

40. Sullivan T, Davis SC, Cazzaniga AL, and Mertz PM. A new model for studying re-epithelization of partial thickness wounds in hypoxic skin.Wounds 2001:13;1 24-28.

41. Anwer K, Earle HC, Shi M, Wang J, Mumper RJ, Proctor B, Jansa K, Ledebur HC, Davis SC, Ealgstein WH, Rolland AP: Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. Phar Res, 1999 June, 16:6, 889-95

42. Davis SC, Badiavas V, Rendon-Pellerano M, and Pardo RJ: Comparison of Postoperative Treatment for Laser Resurfacing. Derm Surg 1999; 25:387-393

43. Mertz PM, Oliverira-Gandia MF and Davis SC: The evaluation of a cadexomer iodine wound dressing on methicllin resistant staphylococcus aureus (MRSA) in acute wounds Derm Surg 1999;25:89-93.

44. Oliveria MF, Davis SC and Mertz PM: Can occlusive dressing composition influence proliferation of bacterial wound pathogens? Wounds 10(1):4-11,1998.

45. Davis SC, Bilevich ED, Cazzaniga AL and Mertz PM: Early Debridement of Second-Degree Burn Wounds Enhances the Rate of Epithelization / An Animal Model to Evaluate Burn Wound Therapies. J Burn Care and Rehabilitation 17:558-61, 1996

46. Mertz PM, Davis SC, Oliveira-Gandia MF, and Eaglstein WH. The Wound Environment: Implications from Research Studies for Healing and Infection. Wounds 8(1) 1-8, 1996.

47. Mertz PM, Davis SC, Franzén L, Uchima FD, Pickett MP, Pierschbacher MD, Polarek JW: Effect of an RGD Peptide-Containing Artificial Matrix on Epithelial Sheet Migration and Experimental Second-Degree Burn Wound Healing. J Burn Care and Rehabilitation 17(3): 199-206, 1996.

48. Kaiser ME, Davis SC, Mertz PM: The Effect of Ultraviolet Irradiation-Induced Inflammation on Epidermal Wound Healing. Wound Rep Reg 3:3: 311-315, 1995

49. Mertz PM, Davis SC, Brewer LD, Franzén L: Can Antimicrobials be Effective Without Impairing Wound Healing?: The Evaluation of a Cadexomer Iodine Ointment. Wounds. 6(6):184-193, 1994.

50. Mertz PM, Davis SC, Cazzaniga AL, Cheng K, Reich JD, Eaglstein WH: Electrical Stimulation: Acceleration of Soft Tissue Repair by Varying Polarity. Wounds 5:3, 153-159, 1993.

51. Mertz PM, Sauder DL, Davis SC, Killian PL, Herron AJ and Eaglstein WH: IL-1 as a potent inducer of wound re-epithelialization. Prog Clin Biol Res 1991:365:473-80.

52. Sauder DN, Kilian PL, McLane JA, Quick TW, Jakubovic H, Davis SC, Eaglstein WH, and Mertz PM: Interleukin 1 enhances Epidermal Wound Healing. Lymphokin Res. 9:4;465-473, 1990.

53. Davis SC, Mertz PM and Eaglstein WH. Second Degree Burn Healing: The Effect of Occlusive Dressings and a Cream. J. Surg. Res. 48:245-248, 1990.

54. Eaglstein WH, Davis SC, Mehle AL, Mertz PM: Optimal use of an occlusive dressing to enhance healing. Arch. Dermatol., 124(3):392-5, 1988.